You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

39 search results for: disease background

Diagnostic Considerations: Coexistence, and Distinctions of AD & PN
expert video

Diagnostic Considerations: Coexistence, and Distinctions of AD & PN

Dermatology
Dr. Mark Tang talks about the coexistence of AD and PN and considerations for choosing treatment.
View more
AD and PN: Commonalities and Differences – A Case Study
expert video

AD and PN: Commonalities and Differences – A Case Study

Dermatology
Highlights from the WCD 2023 ADVENT symposium, analyzing case studies and linked comorbidities in relation to atopic dermatitis and prurigo nodularis.
View more
Type 2 Inflammation Alters the Structure and Function of the Skin in AD
expert video

Type 2 Inflammation Alters the Structure and Function of the Skin in AD

Dermatology
Highlights from the WCD 2023 ADVENT symposium, analyzing case studies and linked comorbidities in relation to atopic dermatitis and prurigo nodularis.
View more
Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU
expert video

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU

Dermatology
Dr. Elmariah introduces the multiple roles of type 2 cytokines in chronic itch.
View more
Exploring Neurosensitization and Pain in Prurigo Nodularis
expert video

Exploring Neurosensitization and Pain in Prurigo Nodularis

Dermatology
Dr. Gil Yosipovitch explains that patients with PN may experience pain due to neurosensitization.
View more
Novel Treatments for Bullous Pemphigoid
expert video

Novel Treatments for Bullous Pemphigoid

Dermatology
Join Dr. Murell as she shares novel treatments for bullous pemphigoid and how these may help fill current gaps in treatment options.
View more
Etiology and Diagnosis of Bullous Pemphigoid
expert video

Etiology and Diagnosis of Bullous Pemphigoid

Dermatology
Professor Joost Meijer discusses the complex etiology and diagnosis of BP
View more
Diagnosis of Bullous Pemphigoid Interactive Patient Case
interactivity

Diagnosis of Bullous Pemphigoid Interactive Patient Case

Dermatology
An interactive patient case tool involving a deeper dive into assessing clinical presentation when diagnosing bullous pemphigoid (BP)
View more
Explore the Global Burden of Pediatric AD (PEDISTAD)
interactivity

Explore the Global Burden of Pediatric AD (PEDISTAD)

Dermatology
This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.
View more
ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP

Rhinology
Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP
View more
Effect of Type 2 Inflammation on Skin Barrier Function in AD​
interactivity

Effect of Type 2 Inflammation on Skin Barrier Function in AD​

Dermatology
Gain insights on how type 2 inflammation affects different aspects of skin barrier function – an interactive educational tool.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region